If that's all he does he will be indicted. What can

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks farml1234 #44535
194
If that's all he does he will be indicted.

Quote:
What can Robert Mueller do if Trump answers under oath, “I do not remember” or “recollect” and goes off track from the questions?


Geoffrey Beebe

Answered Jan 9

For six months, I observed prosecutors in action. Here’s what I know.

If a suspect only answers “I don’t know” or “I don’t remember/recall” to every question, that’s immediately red flagged as suspicious behavior.

I’ve seen some prosecutors use that tactic alone - barring some form of mental illness, which is unlikely but possible - as grounds for obstruction of justice.

The thing is that sworn testimony only does certain things.

Bank records, investments, corporate purchases, air travel tell a much more concrete story than humans do. Did you know that the government can analyze EZ-Pass records? After all, government roads and whatnot.

You piss off the wrong prosecutor, and you better believe they can piece your life together better than you can. You think you know your life? Get an investigator to summarize your last 12 months. You can bet your butt they will.

Here’s the thing: if Trump were as smart as he thinks he is, he’d say the occasional “I don’t know/I don’t recall.” Except anyone paying attention to how he talks knows he’s not going to do that. He’s going to chump around and give verbal diarrhea. In either case, I think Mueller has a better story from the records than from any testimony he’ll be given.

He needs the lower-tiered folk to go after the big fish. That human testimony will matter.



Quote:
John Tracker, M.S. Education & Psychology, University of California, Berkeley (1997)

Answered Jan 9 · Author has 386 answers and 110.8k answer views

The “I don’t recall” defense is weak and a good prosecutor will tie a defendant down with questions that has documentation and eye witnesses so using that defense only makes it obvious the defendant is lying and could be grounds for impeachment.

Keep in mind that this investigation will also be included in a report to the DOJ and congress to consider impeachment and that is a political not criminal process and only requires the appearance of high crimes and misdemeanors.

Can Trump plead the 5th? It's complicated!

Reports are that Trump's lawyers and Mueller's team are in discussion to set up parameters under which Trump will be required to testify under oath.

The fact is Mueller holds all the cards on this decision and he has the authority to subpoena Trump to testify under oath to the grand jury.

Trump's lawyers are hoping to make a deal with Mueller to let Trump testify in some other way because they know Trump is not capable of being grilled under oath by trained professional Federal prosecutors without screwing up and perjuring himself or saying too much and incriminating himself and others.

Grand Juries are not like State Courts

Grand juries are different than state court proceedings. The defense lawyers are not even allowed to be in the room during testimony. They can be out in the hall and the defendant can go out and speak to their lawyers during the hearing for legal advice but in the hearing they are on their own.

There is no blanket protection of the 5th amendment

There is also no blanket protection of the 5th amendment. Trump can't just say he pleads the 5th to everything and refuse to testify. The law is clear that the 5th amendment only applies to answers that might incriminate the person giving testimony not other people and that incrimination must be valid that it indicates the person pleading the 5th has “real risk that [if you were to testify] your answers would tend to indicate your involvement in illegal activity[,]” Commonwealth v. Martin, 423 Mass. 496 (1996).

https://www.bostondefenselaw.com...

Consider that carefully because pleading the 5th is basically an admission you believe you may have been involved in some illegal activity.

That in itself would be grounds for congress to begin impeachment hearings as the president and all Federal officials swear an oath to uphold the constitution and laws of the land and pleading the 5th is an admission you have violated that duty.

So Trump's lawyers are in a very tough spot because they don't want Trump to testify and they don't want him to plead the 5th because either way he is likely to end up being impeached and Trump can not use the pardon power in cases of impeachment which is his only hole card to save himself and his kids from Federal charges.

They have only two real options:

1- Try to get Mueller to compromise on some form of testimony like written responses instead of an in person interview so Trump's lawyers can control his responses to keep him from perjuring himself or revealing too much and incriminating himself.

2- Convince Trump he can not testify no matter what and he should pardon himself and his kids and resign and refuse to testify. That would prevent impeachment and prevent Federal charges against Trump and his kids and then they can fight state charges for years if they are charged at the state level.

Summary

Trump's lawyers are trying to accomplish that first option now to make a deal with Mueller but if that falls through (which is likely) expect them to push Trump to strongly consider his second and only real option to pardon himself and his kids and resign.



1
Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 139

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 190

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Kearney's 2025 Global Cities Report Insights

Updated Category News Views 654

Global Cities Adapt to New Challenges and Emergence Global cities hold steady at the top as new hubs surge forward Top cities reaffirm their dominance in the Global Cities Index, showcasing remarkable resilience amidst global changes and uncertainties. The Global Cities Outlook indicates a noticeable shift as traditional leaders face turbulence, while emerging Gulf and...

Continue Reading
Vacca Family Law Group Enhances Support for Peaceful Divorce

Updated Category News Views 255

Empowering Families Through Non-Adversarial Divorce Solutions Families navigating the challenging process of separation now have renewed access to considerate and non-confrontational divorce options. Vacca Family Law Group has recently welcomed Attorney and Mediator Wendy Reimer, who brings nearly two decades of experience in family law and a strong background in...

Continue Reading
Ingredion Delivers Impressive Q3 Results, Upgrades Outlook

Updated Category News Views 55

Ingredion's Strong Performance in the Third Quarter Ingredion Incorporated (NYSE: INGR) has reported remarkable results for the third quarter of 2024, showcasing a noteworthy surge in both operating income and earnings per share (EPS). The global leader in ingredient solutions for the food and beverage industry achieved a stunning 26% increase in reported operating income...

Continue Reading
Insight into Learning Technologies Group Plc's Disclosure Mechanism

Updated Category News Views 193

Understanding the Public Opening Position Disclosure Process In the complex world of financial securities, understanding the disclosure requirements can feel daunting. However, the process outlined by the Takeover Code, particularly Rule 8.3, provides a structured approach for individuals and entities holding significant interests in relevant securities. This rule is...

Continue Reading
Avidity Biosciences Set to Inspire with Latest Presentations

Updated Category News Views 191

Avidity Biosciences' Key Presentations at the MDA Conference Avidity Biosciences, Inc. (Nasdaq: RNA), a pioneer in RNA therapeutics, is poised to make a significant impact at the upcoming Clinical and Scientific Conference organized by the Muscular Dystrophy Association (MDA). The event will showcase the latest advancements in the field and highlight groundbreaking...

Continue Reading